Suppr超能文献

相似文献

2
Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature.
J Gastroenterol Hepatol. 2002 Jan;17(1):6-16. doi: 10.1046/j.1440-1746.2002.02596.x.
3
Pathology of idiopathic non-cirrhotic portal hypertension.
Virchows Arch. 2018 Jul;473(1):23-31. doi: 10.1007/s00428-018-2355-8. Epub 2018 Apr 12.
4
Obliterative portal venopathy without portal hypertension: an underestimated condition.
Liver Int. 2016 Mar;36(3):454-60. doi: 10.1111/liv.12936. Epub 2015 Sep 6.
5
Histopathological features of idiopathic portal hypertension: A systematic review and meta-analysis.
Sci Prog. 2024 Jul-Sep;107(3):368504241264996. doi: 10.1177/00368504241264996.
6
Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
Liver Int. 2016 Jul;36(7):1059-66. doi: 10.1111/liv.12974. Epub 2015 Oct 19.
9
Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
Ir J Med Sci. 2023 Aug;192(4):1657-1660. doi: 10.1007/s11845-022-03153-0. Epub 2022 Sep 17.
10
Porto-sinusoidal vascular disorder.
J Hepatol. 2022 Oct;77(4):1124-1135. doi: 10.1016/j.jhep.2022.05.033. Epub 2022 Jun 9.

引用本文的文献

2
A novel mutation associated with idiopathic portal hypertension: Case report and literature review.
ILIVER. 2022 Jul 14;1(2):90-95. doi: 10.1016/j.iliver.2022.06.001. eCollection 2022 Jun.
4
Idiopathic non-cirrhotic portal hypertension: A case report.
Medicine (Baltimore). 2024 Dec 20;103(51):e40642. doi: 10.1097/MD.0000000000040642.
5
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.
Hepatol Int. 2024 Dec;18(6):1684-1711. doi: 10.1007/s12072-024-10739-6. Epub 2024 Nov 15.
6
Histopathological features of idiopathic portal hypertension: A systematic review and meta-analysis.
Sci Prog. 2024 Jul-Sep;107(3):368504241264996. doi: 10.1177/00368504241264996.
7
Porto-sinusoidal vascular disease: a new definition of an old clinical entity.
Clin Exp Hepatol. 2023 Dec;9(4):297-306. doi: 10.5114/ceh.2023.133107. Epub 2023 Nov 24.
8
Porto-sinusoidal Vascular Disease: Classification and Clinical Relevance.
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101396. doi: 10.1016/j.jceh.2024.101396. Epub 2024 Mar 12.
10
A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis.
Diagnostics (Basel). 2023 Oct 20;13(20):3263. doi: 10.3390/diagnostics13203263.

本文引用的文献

1
Noncirrhotic portal hypertension.
Clin Liver Dis. 1997 May;1(1):223-40, xiii. doi: 10.1016/s1089-3261(05)70265-8.
2
Venous thrombosis: a multicausal disease.
Lancet. 1999 Apr 3;353(9159):1167-73. doi: 10.1016/s0140-6736(98)10266-0.
3
Centrilobular and perisinusoidal fibrosis in experimental congestive liver in the rat.
J Hepatol. 1999 Mar;30(3):433-9. doi: 10.1016/s0168-8278(99)80102-0.
4
Evaluation of hepatocyte injury following partial ligation of the left portal vein.
J Hepatol. 1999 Jan;30(1):29-37. doi: 10.1016/s0168-8278(99)80005-1.
6
Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis.
Eur J Gastroenterol Hepatol. 1997 May;9(5):485-9. doi: 10.1097/00042737-199705000-00014.
9
Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology.
Histopathology. 1996 Mar;28(3):195-204. doi: 10.1046/j.1365-2559.1996.d01-412.x.
10
Idiopathic portal hypertension.
Hepatology. 1993 Jun;17(6):1157-62.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验